Fundraising Fox

Brandon Capital Partners

Venture capital

Seed–Growth

Fox Verdict
Sign up to see your fit

Investment thesis

Brandon Capital is a life sciences venture capital firm that invests in biotech and medical research companies, with investors and venture partners across Australia, New Zealand, the United States and the United Kingdom.

Source: firm website, verified Aug 3, 2026.

Stage
Seed–Growth
Instruments
Equity
Tracked investments
4

What they invest in

from 2 of 4 portfolio companies

Biotech ×2Deep Tech ×1Healthtech ×1Medical Devices ×1

HQs:Australia×1United Kingdom×1

Investments · 4 tracked

founders shown can be your intro path
Brandonbiocatalystbrandonbiocatalyst.com

Brandon BioCatalyst is a life science investment fund and venture capital organization that partners with entrepreneurs to build and run companies commercializing medical research.

BiotechDeep TechHealthtech

Myricx Biomyricxbio.com

Myricx is a biotech company developing a new class of payloads for antibody drug conjugates (ADCs) based on inhibitors of N-myristoyltransferase (NMT) enzymes, aimed at treating cancer.

BiotechMedical DevicesLondon, GB

Co-investorsNovo HoldingsSofinnova Partners

OccuRxoccurx.com

Therapies for fibrotic and inflammatory diseases associated with diabetes complications

Co-investorsStoic VCBrandon BioCatalyst

Perxbrandoncapital.vcin

Co-investorsBrandon BioCatalyst

Frequently asked questions

What stage does Brandon Capital Partners invest at?
Brandon Capital Partners invests at the Seed, Series A, Series B, Series C, Growth stages.
What sectors does Brandon Capital Partners focus on?
Brandon Capital Partners focuses on Biotech, Deep Tech, Digital Health, Healthtech, Medical Devices.
Who does Brandon Capital Partners co-invest with?
Brandon Capital Partners most often shares deals with Brandon BioCatalyst, Novo Holdings, Sofinnova Partners, among 3 tracked co-investors.

Images

Brandon Capital Partners photo

Similar investors

Featured in lists